Clinical TrialsSearch results
Number of results: 957
Other
- Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2009-04-01
Other
- A genotype directed dose-finding study of Irinotecan (CPT-11) by groups of Uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with advanced metastatic colorectal cancer and gastric cancer.
- colorectal cancer/ gastric cancer
- Yakult Honsha Co.,Ltd
- 2006-11-01
Completed
- Study of patch test allergens
- Allergic contact dermatitis
- Yagami Akiko
- 2021-08-30
Recruiting
- Study on Establishment of Allergy Confirmation Method for Cosmetics and Others
- Allergic contact dermatitis
- Yagami Akiko
- 2019-03-18
Recruiting
- Gifu Metformin and Seirogan Study
- Type 2 Diabetes Mellitus
- Yabe Daisuke
- 2023-02-24
Not yet recruiting
- Phase 3 Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
- Participants with IgAN
- Wuebbenhorst Hiroaki
- 2024-04-12
Other
- A Randomized Phase III trial of chemotherapy alone versus chemotherapy followed by gefitinib in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV Non-small cell lung cancer
- West Japan Thoracic Oncology Group (WJTOG)
- 2005-09-04
Other
- To evaluate whether two weekly concurrent chemoradiotherapy regimens offer any advantage over concurrent chemoradiotherapy regimens with Cisplatin, Vindesine, Mitomycin for unresectable stage III NSCLC
- unresectable stage III NSCLC
- West Japan Oncology Group
- 2005-08-29
Other
- randomized study of Gemicitabine alone or UFT adjuvant chemotherapy for stage IB-IIIA non small cell lung cancer after complete resection
- stage IB-IIIA non small cell lung cancer after complete resection
- West Japan Oncology Group
- 2005-09-06
Other
- Randomized phase III study of FOLFOX plus bevacizumab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer
- metastatic colorectal cancer
- West Japan Oncology Group
- 2008-09-26